A gloved hand tapping white powder from a spatula into a weighing boat on a laboratory balance

AI-generated image.

The short answer: the active and its percentage decide the procedure

To sell a product in Korea with a skin-brightening or anti-wrinkle claim, the product has to be a functional cosmetic, and before it is sold it must either pass a review or be covered by a filed report. Which of the two applies is mostly decided by which active ingredient you use and at what concentration. An active that appears in the MFDS notice, used at the listed concentration, removes most of the data burden. An active outside the list, or a different concentration, means a review supported by safety and efficacy data.

That is why this decision belongs in the brief, not at the end of formulation. This article sets out what a brand planning a serum or cream should settle before contacting a manufacturer.

1. "Brightening" and "anti-wrinkle" are functions defined by law

Article 2(2) of the Korean Cosmetics Act (Act No. 22113, in force 20 October 2026) defines functional cosmetics and names, among others, products that help brighten (whiten) the skin and products that help improve skin wrinkles. Article 2 of the Enforcement Rule (Prime Ministerial Decree No. 2109, in force 2 April 2026) describes the scope more precisely:

A cosmetics manufacturer, a responsible seller of cosmetics, or a university or research institute that wants a product recognised and sold with one of these functions must, for each product, either obtain a review or file a report, and the same applies when a reviewed item or a filed report is changed (Act, Article 4(1)). A functional cosmetic that has neither been reviewed nor reported may not be sold, or manufactured, imported, stored or displayed for sale (Act, Article 15, item 1).

2. Two routes: report and review

A report means filing a "Report on Functional Cosmetics Excluded from Review" with the head of the National Institute of Food and Drug Safety Evaluation (Enforcement Rule, Article 10(2)). Article 10(1) of the Enforcement Rule defines which products qualify. This article looks at two of its categories (item 3, on products that combine sunscreen actives with these actives, is not covered here).

A review covers everything else. For each product, the applicant submits a review request with the following data (Enforcement Rule, Article 9(1)):

The proviso to the same paragraph states that for items whose ingredient and content have been notified, the first groups of data may be omitted, and for items whose specifications and test methods have been notified, the specifications and test methods data may be omitted. In other words, "is it a notified active?" and "do the specifications and test methods also match the notice?" are two separate questions, and each needs its own answer.

3. The actives and concentrations in the notice

Annex 4 of the MFDS notice Regulation on the Review of Functional Cosmetics, titled "Types of functional cosmetics for which data submission is omitted", lists the ingredients and contents below. Article 6(3) of the notice exempts items whose ingredient and content are listed in Annex 4 from submitting origin and development, safety and efficacy data. The ingredient names are English renderings of the Korean names used in the notice.

Scroll horizontally to see all columns when the table is wider than your screen.

FunctionIngredientContent
BrighteningPaper mulberry extract2%
BrighteningArbutin2 to 5%
BrighteningEthyl ascorbyl ether1 to 2%
BrighteningOil-soluble licorice extract0.05%
BrighteningAscorbyl glucoside2%
BrighteningMagnesium ascorbyl phosphate3%
BrighteningNiacinamide2 to 5%
BrighteningAlpha-bisabolol0.5%
BrighteningAscorbyl tetraisopalmitate2%
Anti-wrinkleRetinol2,500 IU/g
Anti-wrinkleRetinyl palmitate10,000 IU/g
Anti-wrinkleAdenosine0.04%
Anti-wrinklePolyethoxylated retinamide0.05 to 0.2%

Three conditions have to be read together with the table. All three are written in Annex 4.

The content above was checked in the version published on the Korea Law Information Center as MFDS Notice No. 2026-75 (partially amended 10 November 2026, in force 11 November 2027). The stated reasons for that amendment describe it as concerning the data requirements and exemptions for sunscreen products. Notices are amended from time to time, so the version in force when you lock the product should be confirmed again with your manufacturer.

4. One "niacinamide serum", different routes depending on the brief

Scroll horizontally to see all columns when the table is wider than your screen.

What the brief saysWhat to confirm
A notified active at the notified content, in a listed dosage form with the fixed wordingWhether the specifications and test methods also match the notified item, so that the report route applies
A notified active, but outside the listed contentWhether a review is required, and who prepares which data
A brightening or anti-wrinkle claim based on an active not on the listA review with safety and efficacy data, and its timeline
A formula the manufacturer has already had reviewed, used unchangedWhether the manufacturer that designed, developed and produced it is the same, and whether the earlier item proved efficacy against a control
A general cosmetic with no brightening or anti-wrinkle claimWhether any wording on the label or in advertising could be taken as a functional claim

The last row is also a real option. Including an ingredient and claiming its function are different things, so a product can be launched as a general cosmetic without functional wording. However, labelling or advertising that may cause a non-functional cosmetic to be mistaken for a functional cosmetic is prohibited (Act, Article 13(1)), so the wording you want to use has to be decided first. How wording relates to substantiation is covered in advertising claims and substantiation.

Where a brand wants to combine a brightening active and an anti-wrinkle active in one product and make both claims, this article does not state which procedure applies. That is a product-by-product determination, so confirm it through your manufacturer.

5. Who files, and what changes

The same structure applies to other functions. Sun protection is covered in developing sunscreen, and hair-loss relief in private label shampoo.

6. What to write in your first inquiry

With these six lines, the procedure, the data and the formula can be reviewed together. You can start with a formulation development consultation, and the remaining fields of a brief are covered in writing a product brief. Quantities, unit prices and schedules depend on the product and its conditions and are confirmed in consultation.

Frequently asked questions

Does adding niacinamide automatically make a product a brightening functional cosmetic?

No. To be recognised and sold as a functional cosmetic, each product has to be reviewed or reported (Act, Article 4(1)). The presence of the ingredient alone does not complete that procedure.

What happens if a notified active is used above the notified content?

The content then differs from what Annex 4 lists, so the data exemption tied to that table cannot be assumed to apply as it stands. Which procedure and which data are required should be confirmed with the manufacturer before the formula is locked.

If the manufacturer's formula has already passed a functional review, does our brand's product only need a report?

It can, if the conditions are met. Article 10(1), item 2 of the Enforcement Rule makes a product reportable when the manufacturer that designed, developed and produced it is the same, or the responsible seller is the same, and the type, specification and content of the active raw material, the efficacy statement, the specifications and test methods, the directions and dosage, and the dosage form are all the same. For brightening and anti-wrinkle products, the earlier reviewed item must be one whose efficacy was demonstrated against a control.

Sources